| Cell line name |
MAb-G2 |
|---|
| Synonyms |
G2 |
|---|
| Accession |
CVCL_A6KF |
|---|
| Resource Identification Initiative |
To cite this cell line use: MAb-G2 (RRID:CVCL_A6KF) |
|---|
| Comments |
Monoclonal antibody isotype: IgG1, lambda.
Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). |
|---|
| Species of origin |
Homo sapiens (Human) (NCBI Taxonomy: 9606)
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_3419 (SHM-D33) |
|---|
| Category |
Hybridoma |
|---|
| Publications | PubMed=2091939; DOI=10.1007/BF00151713
Kamei M., Hashizume S., Sugimoto N., Ozutsumi K., Matsuda M.
Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity.
Eur. J. Epidemiol. 6:386-397(1990) PubMed=1572415; DOI=10.1007/BF02427384
Matsuda M., Kamei M., Sugimoto N., Ma Y., Hashizume S.
Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
Eur. J. Epidemiol. 8:1-8(1992) DOI=10.1007/978-94-011-2044-9_84
Matsuda M., Kamei M., Sugimoto N., Hashizume S.
Application of anti-tetanus human monoclonal antibodies.
(In) Animal cell technology. Basic and applied aspects, Vol. 5; Kaminogawa S., Ametani A., Hachimura S. (eds.); pp.617-623; Springer; Dordrecht (1993) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q107115918
|
|---|
| Entry history |
|---|
| Entry creation | 20-May-2021 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 3 |
|---|